Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.

Autor: Kagan KO; Department of Women's Health, University of Tübingen, Tübingen, Germany., Enders M; Laboratory Prof. Gisela Enders & Colleagues MVZ and Institute of Virology, Infectiology and Epidemiology e.V, Stuttgart, Germany., Schampera MS; Institute of Medical Virology and Epidemiology of Viral Diseases, University of Tübingen, Tübingen, Germany., Baeumel E; Institute of Medical Virology and Epidemiology of Viral Diseases, University of Tübingen, Tübingen, Germany., Hoopmann M; Department of Women's Health, University of Tübingen, Tübingen, Germany., Geipel A; Department of Obstetrics and Gynaecology, University of Bonn, Bonn, Germany., Berg C; Department of Obstetrics and Gynaecology, University of Cologne, Cologne, Germany., Goelz R; Department of Neonatology, University of Tübingen, Tübingen, Germany., De Catte L; Department of Obstetrics and Gynaecology, University of Leuven, Leuven, Belgium., Wallwiener D; Department of Women's Health, University of Tübingen, Tübingen, Germany., Brucker S; Department of Women's Health, University of Tübingen, Tübingen, Germany., Adler SP; CMV Research Foundation, Richmond, VA, USA., Jahn G; Institute of Medical Virology and Epidemiology of Viral Diseases, University of Tübingen, Tübingen, Germany., Hamprecht K; Institute of Medical Virology and Epidemiology of Viral Diseases, University of Tübingen, Tübingen, Germany.

Publikováno v: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology [Ultrasound Obstet Gynecol] 2019 Mar; Vol. 53 (3), pp. 383-389. Date of Electronic Publication: 2019 Feb 08.

Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.

Autor: Schampera MS; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany., Schweinzer K; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany., Abele H; Department of Obstetrics and Gynaecology, University Hospital of Tuebingen, Germany., Kagan KO; Department of Obstetrics and Gynaecology, University Hospital of Tuebingen, Germany., Klein R; Department of Internal Medicine II, Immunopathological Laboratory; University Hospital of Tuebingen, Germany., Rettig I; Department of Internal Medicine, Central Laboratory, University Hospital of Tuebingen, Germany., Jahn G; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany., Hamprecht K; Institute of Medical Virology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany. Electronic address: klaus.hamprecht@med.uni-tuebingen.de.

Publikováno v: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2017 May; Vol. 90, pp. 40-45. Date of Electronic Publication: 2017 Mar 16.